Skip to content

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Sahlgrenska EUS ERCP Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03504293
Enrollment
90
Registered
2018-04-20
Start date
2010-01-01
Completion date
2020-12-15
Last updated
2020-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Stricture, Biliary Tract Diseases, Biliary Tract Neoplasms, Neoplasms

Keywords

Endosonography, Endoscopic retrograde choledochography

Brief summary

ERCP with brush cytology has a poor to moderate accuracy in unclear biliary lesions. Endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for cytology may override some of these shortcomings. The current prospective study, performed in a tertiary University center, aims to study the feasibility, the accuracy and the clinical value of combinatory ERCP and EUS in unclear biliary lesions.

Detailed description

The eligible study participants with unclear biliary lesions referred for an ERCP to the Sahlgrenska Univeristy Hospital endoscopy unit will be subjected to ERCP with/without brush cytology followed by EUS with/without FNA. The results of ERCP and EUS will be compared to the pathology report of surgical specimens in resected patients or to clinical follow up at 12 months post-EUS in non-resected patients.

Interventions

PROCEDURECombinatory EUS and ERCP

EUS performed as a supplementary procedure in addition to ERCP

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with unclear lesions or strictures in the biliary tract referred for endoscopy work up

Exclusion criteria

* Patients unwilling to participate * Patients unfit for EUS and ERCP

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy12 months post-EUSOverall accuracy of ERCP and EUS

Secondary

MeasureTime frameDescription
Adverse event rate30 days post-EUSThe number of patients ending up with some type of complication related to ERCP or EUS

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026